AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.
Presence of Particulate Matter.
Consumers and healthcare providers should stop using this product immediately. Contact B BRAUN MEDICAL INC or your healthcare provider for guidance. Notification method: Press Release
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Rosuvastatin Tablets are prescription medications used to lower cholesterol levels in adults. They are often prescribed to reduce the risk of heart disease and related conditions.
The dissolution issue means the tablets may not release the active ingredient as intended, potentially reducing effectiveness and safety.
This recall is not part of a broader industry pattern.
Consumers are advised to stop using the product immediately, which may cause inconvenience for those relying on the medication for cholesterol management.
Look for the lot number and expiration date printed on the carton and individual tablet packaging.
Expect a refund or replacement process to take approximately 4-6 weeks after returning the product.
Keep records of purchase receipts, correspondence with the manufacturer, and any notes on side effects experienced.
The recall involves Rosuvastatin Tablets, USP, 10 mg. The product comes in 50 tablets per carton and was manufactured by AvKARE in Pulaski, TN. The affected lot number is #49124, and the expiration date is December 31, 2026.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
B. Braun Medical Inc. recalled 16,228 3000 mL saline irrigation bags nationwide in the United States. The recall cites lack of assurance of sterility due to port misalignment, creating a potential for fluid leakage. Healthcare providers and patients should stop using the product immediately and contact the company for guidance.
B. Braun Medical Inc. recalls 47,148 containers of 0.9% Sodium Chloride Injection USP nationwide after detecting particulate matter. The Class I recall affects bottles with NDC 0264-7800-09. Stop using and contact providers for guidance.
B. Braun Medical Inc. recalls 23,100 0.9% Sodium Chloride Injection L 8000 containers nationwide. The recall cites lack of assurance of sterility and potential fluid leakage at a weld site. Stop using immediately and consult a healthcare provider.
B. Braun Medical Inc. recalls 74,088 Lactated Ringers Injection USP containers nationwide over sterility concerns. The recall cites potential fluid leakage at weld sites and lack of assurance of sterility. Healthcare providers and patients should stop use and seek guidance from their supplier or provider immediately.